ArticleJournal of pharmaceutical analysis2024

Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC.

Feifei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.